The University of Chicago Header Logo
Last Name


Search Results to Daniel H. Shevrin

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following items that are connected to Shevrin, Daniel

Item TypeName
Concept Bone Neoplasms
Concept Neoplasm Metastasis
Academic Article Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer.
Academic Article A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An Illinois Cancer Center Study.
Academic Article Phase I/II trial of orteronel (TAK-700)--an investigational 17,20-lyase inhibitor--in patients with metastatic castration-resistant prostate cancer.
Academic Article Development of skeletal metastasis by human prostate cancer in athymic nude mice.
Academic Article In vivo and in vitro approaches to study metastasis in human prostatic cancer.
Academic Article The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer.
Academic Article Effect of etidronate disodium on the development of bone lesions in an animal model of bone metastasis using the human prostate cancer cell line PC-3.
Academic Article Constructing a conceptual framework of patient-reported outcomes for metastatic hormone-refractory prostate cancer.
Academic Article Patterns of metastasis by the human prostate cancer cell line PC-3 in athymic nude mice.
Academic Article Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel.
Academic Article Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial.
Academic Article Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012.
Academic Article Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial.

Search Criteria
  • Bone cancer
  • metastasis